Skip to main content

“Efficacy and safety of co administered cagrilintide and semaglutide(CagriSema) once weekly versus placebo in participants with type 2diabetes and painful diabetic peripheral neuropathy

Open
  • Protocol code: NN9388-7864
  • EudraCT code: No aplica
  • Research group: Diabetes and Metabolism
  • Service: Endocrinology
  • Principal investigator:  Ortiz Zuñiga, Angel Michael
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Phase: Fase II
  • Status: Recruiting volunteers